Andrew Redfern
Andrew Redfern
University of Western Australia, Harry Perkins Institute of Medical Research
Verified email at
Cited by
Cited by
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer
BIG 1-98 Collaborative Group
New England Journal of Medicine 361 (8), 766-776, 2009
[177Lu] Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
MS Hofman, L Emmett, S Sandhu, A Iravani, AM Joshua, JC Goh, ...
The Lancet 397 (10276), 797-804, 2021
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical …
MM Regan, P Neven, A Giobbie-Hurder, A Goldhirsch, B Ejlertsen, ...
The lancet oncology 12 (12), 1101-1108, 2011
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International …
G Viale, A Giobbie-Hurder, MM Regan, AS Coates, MG Mastropasqua, ...
Journal of clinical oncology 26 (34), 5569, 2008
Controversies around epithelial–mesenchymal plasticity in cancer metastasis
ED Williams, D Gao, A Redfern, EW Thompson
Nature Reviews Cancer 19 (12), 716-732, 2019
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
M Rabaglio, Z Sun, KN Price, M Castiglione-Gertsch, H Hawle, ...
Annals of oncology 20 (9), 1489-1498, 2009
Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib
KM Giles, FC Kalinowski, PA Candy, MR Epis, PM Zhang, AD Redfern, ...
Molecular cancer therapeutics 12 (11), 2541-2558, 2013
SLIRP, a small SRA binding protein, is a nuclear receptor corepressor
EC Hatchell, SM Colley, DJ Beveridge, MR Epis, LM Stuart, KM Giles, ...
Molecular cell 22 (5), 657-668, 2006
RNA-induced silencing complex (RISC) Proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators
AD Redfern, SM Colley, DJ Beveridge, N Ikeda, MR Epis, X Li, CE Foulds, ...
Proceedings of the national academy of sciences 110 (16), 6536-6541, 2013
Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/HER2-negative breast cancer—the evaluating treatment with …
L Gianni, M Mansutti, A Anton, L Calvo, G Bisagni, B Bermejo, ...
JAMA oncology 4 (3), 302-308, 2018
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
M Colleoni, W Luo, P Karlsson, J Chirgwin, S Aebi, G Jerusalem, P Neven, ...
The lancet oncology 19 (1), 127-138, 2018
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer
C Duffy, A Sorolla, E Wang, E Golden, E Woodward, K Davern, D Ho, ...
NPJ precision oncology 4 (1), 24, 2020
Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics
A Sorolla, E Wang, E Golden, C Duffy, ST Henriques, AD Redfern, ...
Oncogene 39 (6), 1167-1184, 2020
Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial–mesenchymal plasticity
LM McInnes, N Jacobson, A Redfern, A Dowling, EW Thompson, ...
Frontiers in oncology 5, 42, 2015
Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients
PA Candy, MR Phillips, AD Redfern, SM Colley, JA Davidson, LM Stuart, ...
British journal of cancer 109 (4), 1023-1030, 2013
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu] Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP …
JP Buteau, AJ Martin, L Emmett, A Iravani, S Sandhu, AM Joshua, ...
The Lancet Oncology 23 (11), 1389-1397, 2022
TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group.[177Lu] Lu-PSMA-617 versus cabazitaxel in patients with metastatic …
MS Hofman, L Emmett, S Sandhu, A Iravani, AM Joshua, JC Goh, ...
Lancet 397 (10276), 797-804, 2021
Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines
J Cursons, KJ Leuchowius, M Waltham, E Tomaskovic-Crook, M Foroutan, ...
Cell Communication and Signaling 13 (1), 1-21, 2015
The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome
AD Redfern, LJ Spalding, EW Thompson
Clinical & Experimental Metastasis 35 (4), 285-308, 2018
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study …
J Gligorov, B Ataseven, M Verrill, M De Laurentiis, KH Jung, HA Azim, ...
European Journal of Cancer 82, 237-246, 2017
The system can't perform the operation now. Try again later.
Articles 1–20